CY1117378T1 - INDIAZOLIS SUSPENSIONS TOY WNT SIGNIFICANT TRANSFER TRAFFIC AND THEIR THERAPEUTIC USES - Google Patents

INDIAZOLIS SUSPENSIONS TOY WNT SIGNIFICANT TRANSFER TRAFFIC AND THEIR THERAPEUTIC USES

Info

Publication number
CY1117378T1
CY1117378T1 CY20161100001T CY161100001T CY1117378T1 CY 1117378 T1 CY1117378 T1 CY 1117378T1 CY 20161100001 T CY20161100001 T CY 20161100001T CY 161100001 T CY161100001 T CY 161100001T CY 1117378 T1 CY1117378 T1 CY 1117378T1
Authority
CY
Cyprus
Prior art keywords
wnt
indiazolis
toy
suspensions
therapeutic uses
Prior art date
Application number
CY20161100001T
Other languages
Greek (el)
Inventor
John Hood
David Mark Wallace
Sunil Kumar Kc
Original Assignee
Samumed, Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP10808589.5A external-priority patent/EP2464232B1/en
Application filed by Samumed, Llc filed Critical Samumed, Llc
Publication of CY1117378T1 publication Critical patent/CY1117378T1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Γνωστοποιούνται ενώσεις ινδαζόλης για την αντιμετώπιση διαφόρων ασθενειών και παθολογιών. Πιο συγκεκριμένα, η παρούσα εφεύρεση αφορά τη χρήση μιας ένωσης ινδαζόλης ή αναλόγων της, στην αντιμετώπιση διαταραχών που χαρακτηρίζονται από την ενεργοποίηση του Wnt μονοπατιού μεταγωγής σήματος (π.χ., καρκίνων, ανώμαλου κυτταρικού πολλαπλασιασμού, αγγειογένεσης, νόσου Alzheimer's και οστεοαρθρίτιδας), τον συντονισμό κυτταρικών διεργασιών που ρυθμίζονται από το Wnt μεταγωγικό μονοπάτι, καθώς επίσης και από γενετικές ασθένειες που οφείλονται σε μεταλλάξεις των μεταγωγών του Wnt μονοπατιού. Επιπλέον, παρέχονται μέθοδοι για την αντιμετώπιση καταστάσεων ασθενειών που σχετίζονται με το Wnt μονοπάτι.Indazole compounds for the treatment of various diseases and pathologies are disclosed. More particularly, the present invention relates to the use of an indazole compound or analogs thereof in the treatment of disorders characterized by activation of the Wnt signal transduction pathway (e.g., cancers, abnormal cell proliferation, angiogenesis, Alzheimer's disease, and osteoarthritis). coordination of cellular processes regulated by the Wnt pathway, as well as by genetic diseases due to mutations in the Wnt pathway transitions. In addition, methods are provided to deal with disease states associated with the Wnt pathway.

CY20161100001T 2009-08-10 2016-01-04 INDIAZOLIS SUSPENSIONS TOY WNT SIGNIFICANT TRANSFER TRAFFIC AND THEIR THERAPEUTIC USES CY1117378T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23260309A 2009-08-10 2009-08-10
US30545910A 2010-02-17 2010-02-17
EP10808589.5A EP2464232B1 (en) 2009-08-10 2010-08-09 Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof

Publications (1)

Publication Number Publication Date
CY1117378T1 true CY1117378T1 (en) 2017-04-26

Family

ID=58606615

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20161100001T CY1117378T1 (en) 2009-08-10 2016-01-04 INDIAZOLIS SUSPENSIONS TOY WNT SIGNIFICANT TRANSFER TRAFFIC AND THEIR THERAPEUTIC USES

Country Status (1)

Country Link
CY (1) CY1117378T1 (en)

Similar Documents

Publication Publication Date Title
CY1119485T1 (en) Indazole Suspensions of the WNT Signaling Pathway and Their Therapeutic Uses
CY1124302T1 (en) ISOQUINOLIN-3-YL CARBOXAMIDES AND THEIR PREPARATION AND USE
CY1122795T1 (en) INDAZOLE-3-CARBOXAMIDES AND THEIR USE AS INHIBITORS OF THE WNT/B-CATENIN SIGNALING PATHWAY
CY1119194T1 (en) INDOLO AND INDOZOLO COMPOUNDS ACTIVATING AMPK
MX2015008860A (en) 3-(benzoimidazol-2-yl)-indazole inhibitors of the wnt signaling pathway and therapeutic uses thereof.
CY1119123T1 (en) BIS-ARYLOSYCLOSED ARYLOTRIAZOLONES AND THEIR USE
CY1117726T1 (en) POSITIVE ALLOYSTERIC RETURNS M1 KINOLINAMIDE RECEPTORS
CY1118061T1 (en) HETEROCYCLYL BICYCLE DERIVATIVES AS KINASE FGFR FOR THERAPEUTIC USE
CY1109104T1 (en) 1,2,3,4 TETRA-SUBSTITUTE INDOLOGY FOR TREATMENT OF RESPIRATORY DISEASES
CY1117372T1 (en) Substituted 5-fluoro-1H-pyrazolopyridines and their use
EA201071057A1 (en) DERIVATIVES OF AZETIDINE AND CYCLUBUTAN AS JAK-KINAZ INHIBITORS
MA39763A (en) 5-substituted indazole-3-carboxamides and preparation and use thereof
CY1116452T1 (en) POSITIVE ALLOYSTELE REGULATORS M1 RECEPTORS OF PYRANYL ARYL Methyl Methyl Benzyl
CY1116057T1 (en) KINAZOLIN-4 (3H) -ONE DERIVATIVES USED AS RI3
CY1111757T1 (en) XANTHINI PRODUCTS AS ELECTRIC SUSPENSIONS HM74A
CY1116315T1 (en) KINAZOLIN-4 (3H) -ONE DERIVATIVES USED AS RI3
CY1111702T1 (en) INDOLO PRODUCERS AS S1P1 RECEPTOR RACE
EA201200952A1 (en) DERIVATIVES OF PYRAZINE AND THEIR APPLICATION FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
CY1108347T1 (en) IMIDAZOLI UNIONS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
EA201391106A1 (en) NEW HETEROCYCLIC DERIVATIVES
EA201490888A1 (en) NEW PURIN DERIVATIVES AND THEIR APPLICATION FOR THE TREATMENT OF DISEASE
EA201071144A1 (en) HETEROCYCLIC DERIVATIVES
EA201270480A1 (en) NEW CONNECTIONS
CU24087B1 (en) CARBAZOL COMPOUNDS
EA200901042A1 (en) DERIVATIVES 1-BENZULFONIL-1H-INDOL AS ACTIVITY INHIBITORS CCR9